Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37515427)

  • 1. sTRBC1 and cyTRBC1 Expression Distinguishes Indolent T-Lymphoblastic Proliferations From T-Lymphoblastic Leukemia/Lymphoma.
    Liu J; Li M; Fu J; Dong M; Fan X; Zhong L; Xu G; Li Y; Xi Q
    Am J Surg Pathol; 2023 Nov; 47(11):1325-1331. PubMed ID: 37515427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow Cytometric Evaluation of Surface and Cytoplasmic TRBC1 Expression in the Differential Diagnosis of Immature T-Cell Proliferations.
    Horna P; Otteson GE; Shi M; Jevremovic D; Yuan J; Olteanu H
    Am J Clin Pathol; 2022 Jan; 157(1):64-72. PubMed ID: 34302330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cyTRBC1 evaluation rapidly identifies sCD3-negative peripheral T-cell lymphomas and reveals a novel type of sCD3-negative T-cell clone with uncertain significance.
    Lu C; Li M; Fu J; Fan X; Zhong L; Li Y; Xi Q
    Cytometry B Clin Cytom; 2024 May; ():. PubMed ID: 38818861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations.
    Brar N; Butzmann A; Kumar J; Peerani R; Morgan EA; Grigoriadis G; Kumar B; Tatarczuch RM; Warnke RA; Ohgami RS
    Histopathology; 2020 Dec; 77(6):984-988. PubMed ID: 32526041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report.
    Han W; Wang B; Yong X; Zhang Y; Shao M; Wang C
    Pathol Oncol Res; 2023; 29():1611151. PubMed ID: 37252318
    [No Abstract]   [Full Text] [Related]  

  • 6. Indolent T-lymphoblastic proliferation concomitant with acinic cell carcinoma mimicking T-lymphoblastic lymphoma: case report and literature review.
    Yasuda H; Tsutsui M; Ota Y; Tanaka M; Komatsu N
    Histopathology; 2018 Apr; 72(5):862-866. PubMed ID: 29143359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolent T-lymphoblastic proliferation associated with Castleman disease and low grade follicular dendric cell sarcoma: report of a case and review of literature.
    Chen J; Feng J; Xiao H; Ma Q; Chen Z
    Int J Clin Exp Pathol; 2019; 12(4):1497-1505. PubMed ID: 31933967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker.
    Zanelli M; Loscocco GG; Sabattini E; Zizzo M; Sanguedolce F; Panico L; Fanni D; Santi R; Caprera C; Rossi C; Soriano A; Cavazza A; Giunta A; Mecucci C; Vannucchi AM; Pileri SA; Ascani S
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34205834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single Antibody Detection of T-Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance.
    Shi M; Jevremovic D; Otteson GE; Timm MM; Olteanu H; Horna P
    Cytometry B Clin Cytom; 2020 Jan; 98(1):99-107. PubMed ID: 30972977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolent T-lymphoblastic proliferation (iT-LBP): a review of clinical and pathologic features and distinction from malignant T-lymphoblastic lymphoma.
    Ohgami RS; Arber DA; Zehnder JL; Natkunam Y; Warnke RA
    Adv Anat Pathol; 2013 May; 20(3):137-40. PubMed ID: 23574769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indolent T-lymphoblastic proliferation involving hepatocellular carcinoma-presentation in novel settings and comprehensive review of literature.
    Ghezavati A; Liang CA; Mais D; Nazarullah A
    J Hematop; 2023 Sep; 16(3):167-175. PubMed ID: 38175402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric evaluation of TRBC1 expression in tissue specimens and body fluids is a novel and specific method for assessment of T-cell clonality and diagnosis of T-cell neoplasms.
    Berg H; Otteson GE; Corley H; Shi M; Horna P; Jevremovic D; Olteanu H
    Cytometry B Clin Cytom; 2021 May; 100(3):361-369. PubMed ID: 32333725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of LEF1 protein expression in diagnosis and differential diagnosis of lymphoblastic lymphoma/acute lymphoblastic leukemia].
    Chen X; Rui WW; Bi K; Wu YJ; Zhang SX; Zhang L; Yu J; Xiu B; Yi XH; Zeng Y
    Zhonghua Bing Li Xue Za Zhi; 2021 Mar; 50(3):207-212. PubMed ID: 33677883
    [No Abstract]   [Full Text] [Related]  

  • 14. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
    Ohgami RS; Zhao S; Ohgami JK; Leavitt MO; Zehnder JL; West RB; Arber DA; Natkunam Y; Warnke RA
    Am J Surg Pathol; 2012 Nov; 36(11):1619-28. PubMed ID: 23060347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric features of incidental indolent T lymphoblastic proliferations.
    Fromm JR; Edlefsen KL; Cherian S; Wood BL; Soma L; Wu D
    Cytometry B Clin Cytom; 2020 May; 98(3):282-287. PubMed ID: 31571375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid evaluation of T cell clonality in the diagnostic work-up of mature T cell neoplasms: TRBC1-based flow cytometric assay experience.
    Capone M; Peruzzi B; Palterer B; Bencini S; Sanna A; Puccini B; Nassi L; Salvadori B; Statello M; Carraresi A; Stefanelli S; Orazzini C; Minuti B; Caporale R; Annunziato F
    Transl Oncol; 2022 Dec; 26():101552. PubMed ID: 36183675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent T-lymphblastic proliferation: report of a case involving the upper aerodigestive tract.
    Yang F; Liu T; Zhao H; Hu Z; Xiao L; Liu Y; Wang X; Li Z
    Int J Clin Exp Pathol; 2014; 7(9):6350-6. PubMed ID: 25337290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expression.
    Ohgami RS; Sendamarai AK; Atwater SK; Liedtke M; Fleming MD; Natkunam Y; Warnke RA
    Am J Surg Pathol; 2014 Sep; 38(9):1298-304. PubMed ID: 24618611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indolent T-lymphoblastic proliferation: a report of three cases.
    Yuanyuan Z; Jianlan X; Yanlin Z; Xiaoge Z
    Virchows Arch; 2022 May; 480(5):1121-1126. PubMed ID: 34482472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.